Media enquiries
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.
Do you have
any question?
Ethypharm Iberia has signed a licensing agreement with Medochemie to commercialize Nefopam HCl 20mg/2ml injectable solution in Spain.
This analgesic provides an effective treatment for moderate to severe pain, addressing a real need for additional therapeutic options in the Spanish market.
This new product reinforces our ambition to grow our portfolio of essential medicines in pain, in line with Ethypharm’s mission to help improve patients’ lives.
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.